Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ras genes are critical regulators of cell signaling.
• Aberrant ras gene activation is implicated in various cancers, including melanoma.
• Identifying specific ras oncogene mutations in melanoma is crucial for understanding tumorigenesis.

Purpose of the Study:

• To investigate the presence and frequency of activated ras oncogenes in solid human sporadic melanomas.
• To utilize a sensitive assay combining DNA-mediated gene transfer and tumorigenicity in mice for detecting ras gene mutations.

Main Methods:

• Employing a DNA-mediated gene transfer assay coupled with tumorigenicity testing in Swiss athymic mice.
• Analyzing 13 independent surgical specimens of primary and metastatic human melanomas.
• Specifically screening for mutations in H-ras, K-ras, and N-ras oncogenes at codons 12, 13, and 61.

Main Results:

• No activated H-ras or K-ras oncogenes were detected in any of the melanoma samples.
• An N-ras oncogene with a mutation at codon 61 was identified in one out of the 13 analyzed melanoma specimens.
• No N-ras oncogenes with mutations at codon 13 were found.

Conclusions:

• The study identified a low frequency of ras gene activation in human sporadic melanomas.
• The employed assay is effective in detecting specific ras oncogene mutations relevant to melanoma development.
• Further research is warranted to explore other genetic alterations contributing to melanoma pathogenesis.